According to Vaxcyte
's latest financial reports the company has NZ$3.14 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | NZ$3.09 B | 81.37% |
2023-12-31 | NZ$1.70 B | 16.44% |
2022-12-31 | NZ$1.46 B | 307.37% |
2021-12-31 | NZ$0.36 B | -32.72% |
2020-12-31 | NZ$0.53 B | 511.22% |
2019-12-31 | NZ$87.56 M | -11.12% |
2018-12-31 | NZ$98.52 M |